424 related articles for article (PubMed ID: 17020964)
21. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
22. CD45 expression in low-grade B-cell non-Hodgkin's lymphomas.
Carulli G; Cannizzo E; Zucca A; Buda G; Orciuolo E; Marini A; Petrini M
Leuk Res; 2008 Feb; 32(2):263-7. PubMed ID: 17692374
[TBL] [Abstract][Full Text] [Related]
23. Inflammatory malignant fibrous histiocytoma: distinction from Hodgkin's disease and non-Hodgkin's lymphoma by a panel of leukocyte markers.
Khalidi HS; Singleton TP; Weiss SW
Mod Pathol; 1997 May; 10(5):438-42. PubMed ID: 9160307
[TBL] [Abstract][Full Text] [Related]
24. VEGF-A promotes lymphoma tumour growth by activation of STAT proteins and inhibition of p27(KIP1) via paracrine mechanisms.
Roorda BD; Ter Elst A; Scherpen FJ; Meeuwsen-de Boer TG; Kamps WA; de Bont ES
Eur J Cancer; 2010 Mar; 46(5):974-82. PubMed ID: 20064707
[TBL] [Abstract][Full Text] [Related]
25. Macrophage/histiocytic antigen CD68 expression in neoplastic and reactive lymph nodes.
Mazur G; Haloń A; Wróbel T; Kuliczkowski K
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():73-5. PubMed ID: 15638380
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical expression of VEGF-A and its ligands in non-neoplastic lesions of the breast sampling-assisted by dynamic angiothermography.
Longatto Filho A; Costa SM; Milanezi F; Montruccoli D; Montruccoli GC; Baltazar F; Schmitt FC
Oncol Rep; 2007 Nov; 18(5):1201-6. PubMed ID: 17914573
[TBL] [Abstract][Full Text] [Related]
27. Cytomorphologic spectrum of small lymphocytic lymphoma in patients with an accelerated clinical course.
Shin HJ; Caraway NP; Katz RL
Cancer; 2003 Oct; 99(5):293-300. PubMed ID: 14579296
[TBL] [Abstract][Full Text] [Related]
28. Phosphorylated VEGFR2/KDR receptors are widely expressed in B-cell non-Hodgkin's lymphomas and correlate with hypoxia inducible factor activation.
Giatromanolaki A; Koukourakis MI; Pezzella F; Sivridis E; Turley H; Harris AL; Gatter KC
Hematol Oncol; 2008 Dec; 26(4):219-24. PubMed ID: 18461646
[TBL] [Abstract][Full Text] [Related]
29. Microvessel density and VEGF/VEGF receptor status and their role in sarcomas of the pulmonary artery.
Gaumann AK; Schermutzki G; Mentzel T; Kirkpatrick CJ; Kriegsmann JB; Konerding MA
Oncol Rep; 2008 Feb; 19(2):309-18. PubMed ID: 18202776
[TBL] [Abstract][Full Text] [Related]
30. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
Balthasar S; Bergelin N; Löf C; Vainio M; Andersson S; Törnquist K
Endocr Relat Cancer; 2008 Jun; 15(2):521-34. PubMed ID: 18509004
[TBL] [Abstract][Full Text] [Related]
31. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
[TBL] [Abstract][Full Text] [Related]
32. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
[TBL] [Abstract][Full Text] [Related]
33. Cytomorphologic characteristics of non-Hodgkin's lymphoma.
Bizjak-Schwarzbartl M
Acta Cytol; 1988; 32(2):216-20. PubMed ID: 2450436
[TBL] [Abstract][Full Text] [Related]
34. Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration.
Sone M; Itoh H; Yamahara K; Yamashita JK; Yurugi-Kobayashi T; Nonoguchi A; Suzuki Y; Chao TH; Sawada N; Fukunaga Y; Miyashita K; Park K; Oyamada N; Sawada N; Taura D; Tamura N; Kondo Y; Nito S; Suemori H; Nakatsuji N; Nishikawa S; Nakao K
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2127-34. PubMed ID: 17872458
[TBL] [Abstract][Full Text] [Related]
35. The role of vascular endothelial growth factors and their receptors in malignant melanomas.
Brychtova S; Bezdekova M; Brychta T; Tichy M
Neoplasma; 2008; 55(4):273-9. PubMed ID: 18505336
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer.
Patel NS; Dobbie MS; Rochester M; Steers G; Poulsom R; Le Monnier K; Cranston DW; Li JL; Harris AL
Clin Cancer Res; 2006 Aug; 12(16):4836-44. PubMed ID: 16914569
[TBL] [Abstract][Full Text] [Related]
37. Deletions at 11q23 in different lymphoma subtypes.
Zhu Y; Monni O; Franssila K; Elonen E; Vilpo J; Joensuu H; Knuutila S
Haematologica; 2000 Sep; 85(9):908-12. PubMed ID: 10980627
[TBL] [Abstract][Full Text] [Related]
38. Constitutive expression of HIF-1alpha and HIF-2alpha in bone marrow stromal cells differentially promotes their proangiogenic properties.
Ben-Shoshan J; Schwartz S; Luboshits G; Maysel-Auslender S; Barzelay A; Polak-Charcon S; Tzahor E; Barshack I; Barak A; Levkovitch-Verbin H; Keren G; George J
Stem Cells; 2008 Oct; 26(10):2634-43. PubMed ID: 18687993
[TBL] [Abstract][Full Text] [Related]
39. Angiogenesis in non-Hodgkin's lymphoma: clinico-pathological correlations and prognostic significance in specific subtypes.
Jørgensen JM; Sørensen FB; Bendix K; Nielsen JL; Olsen ML; Funder AM; d'Amore F
Leuk Lymphoma; 2007 Mar; 48(3):584-95. PubMed ID: 17454603
[TBL] [Abstract][Full Text] [Related]
40. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
